Global Regulatory Science, Gifu Pharmaceutical University, Gifu, Japan.
Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.
J Med Econ. 2021 Jan-Dec;24(1):181-192. doi: 10.1080/13696998.2021.1877149.
As the population in Japan is rapidly aging, the prevalence of dementia, particularly Alzheimer's Disease (AD), is expected to increase, resulting in a growing need for caregivers. This study aims to quantify and compare the humanistic burden of caregivers of AD/dementia patients with caregivers of patients with other conditions in Japan.
This cross-sectional study used data from the 2018 Japan National Health and Wellness Survey (NHWS). Outcome measures included the Short-Form 12-item Health Survey (SF-12) for health-related quality-of-life (HRQoL), EuroQol 5-dimension scale (EQ-5D) for health states utilities, impact of health on productivity and activity, and evaluation of depression and anxiety. Multivariate analysis was used to compare across groups, with adjustment for potential confounding effects.
A total of 805 caregivers of AD/dementia patients, 1,099 other caregivers, and 27,137 non-caregivers were identified. Both AD/dementia caregivers and other caregivers had lower HRQoL and EQ-5D scores, higher total activity impairment, and more caregivers tended to experience anxiety than non-caregivers. There were no significant differences in the involvment in basic and instrumental activities of daily living (ADL) between AD/dementia caregivers and caregivers of other conditions. Notably, AD/dementia caregivers were more involved in making treatment decisions and finance management than other caregivers. Among AD/dementia caregivers caring for one patient, 395 patients lived in the community and 282 in an institution. AD/dementia caregivers whose patients lived in the community were more significantly involved in basic and instrumental ADL. Caregivers of patients with both AD/dementia and cancer had higher caregiving burden than caregivers of patients with either condition.
Caregivers of AD/dementia patients in Japan reportedly experienced significant humanistic burden which is associated with patients' living arrangements and the presence of an additional chronic condition. Therefore, provision of effective care/support is essential to relieve the burden experienced by the caregivers.
随着日本人口的迅速老龄化,痴呆症(尤其是阿尔茨海默病)的患病率预计将增加,从而导致对护理人员的需求不断增长。本研究旨在量化和比较日本阿尔茨海默病/痴呆症患者护理人员与其他疾病患者护理人员的人文负担。
这是一项横断面研究,使用了 2018 年日本国家健康和健康调查(NHWS)的数据。结果测量包括健康相关生活质量的 12 项简明健康调查量表(SF-12),健康状况效用的欧洲五维健康量表(EQ-5D),对生产力和活动的健康影响,以及抑郁和焦虑的评估。采用多变量分析比较各组之间的差异,并进行潜在混杂因素的调整。
共确定了 805 名阿尔茨海默病/痴呆症患者的护理人员、1099 名其他护理人员和 27137 名非护理人员。阿尔茨海默病/痴呆症护理人员和其他护理人员的健康相关生活质量和 EQ-5D 评分均较低,总活动障碍程度较高,且焦虑的护理人员比例高于非护理人员。阿尔茨海默病/痴呆症护理人员和其他疾病护理人员在日常生活活动(ADL)的基本和工具性活动参与方面无显著差异。值得注意的是,阿尔茨海默病/痴呆症护理人员比其他护理人员更参与治疗决策和财务管理。在照顾一位患者的阿尔茨海默病/痴呆症护理人员中,有 395 名患者居住在社区,282 名患者居住在机构中。居住在社区的阿尔茨海默病/痴呆症患者的护理人员更明显地参与了基本和工具性 ADL。同时照顾阿尔茨海默病和癌症患者的护理人员的照护负担比仅照顾一种疾病患者的护理人员更高。
日本阿尔茨海默病/痴呆症患者的护理人员报告称,他们经历了显著的人文负担,这与患者的居住安排和是否存在其他慢性疾病有关。因此,提供有效的护理/支持对于减轻护理人员的负担至关重要。